Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for identification, assessment, prevention, and treatment of T-cell exhaustion using CD39 biomarkers and modulators

Compositions and methods for identification, assessment, prevention, and treatment of T-cell exhaustion using CD39 biomarkers and modulators

US Patent 10927410 · Granted Feb 23, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of assessing the efficacy of a test agent for modulating programmed death2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2025
Modulating biomarkers such as SPP to increase tumor immunity and improve the eff2024
Modulating dsRNA editing, sensing, and metabolism to increase tumor immunity and2024
Antibody molecules to PD-1 and uses thereof2023
Modulating biomarkers to increase tumor immunity and improve the efficacy of can2023
Methods of treating cancer using LSD1 inhibitors in combination with immunothera2023
Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, metho2022
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2022
Methods and compositions for the treatment of persistent infections and cancer b2022
Agents that modulate immune cell activation and methods of use thereof2022
Regulatory T cell PD-1 modulation for regulating T cell effector immune response2021